Home
http://www.virbac.fr/ http://www.boehringer-ingelheim.com/ http://www.novartis.com/ http://www.animalhealth.bayerhealthcare.com/
vetcontact
Vetrinär
Tiermedizin
  WELCOME  
vetcontact
Vetrinär
Tiermedizin
  Home  
  Login / Newsletter  
vetcontact
Vetrinär
Tiermedizin
  CONTACTS  
vetcontact
Vetrinär
Tiermedizin
  Classifieds  
  New Products  
  VetCompanies  
  VetSchools  
vetcontact
Vetrinär
Tiermedizin
  PROFESSION  
vetcontact
Vetrinär
Tiermedizin
  Edutainment  
  VetAgenda  
  Presentations  
  Posters  
  ESAVS  
  Specialisation  
vetcontact
Vetrinär
Tiermedizin
  INSIGHT  
vetcontact
Vetrinär
Tiermedizin
  Congress News  
  Picture Galleries  
vetcontact
Vetrinär
Tiermedizin
  PRODUCTS  
vetcontact
Vetrinär
Tiermedizin
  Bayer  
  Boehringer Ing.  
  Novartis  
  Virbac

 
  Simply book for less...  
    

Bovine    Equine    Small Animal Practice    Swine Practice    Articles    Vetjournal    
deutsch english español polski francais
Home / WELCOME / Archiv / Small Animal Practice /     
 
Vascular endothelial growth factor and receptors in canine mastocytoma cells
Mastocytomas are the most common malignant neoplasias in dogs and much more aggressive than in other species. Recently, the expression of vascular endothelial growth factor (VEGF) - a major regulator of angiogenesis and a potential autocrine growth factor for neoplastic cells in various malignancies - and its receptors have been investigated. These neoplasies show a very unusual expression!

In the present study, we have investigated expression of VEGF and VEGF receptors in canine mastocytomas and the canine mastocytoma cell line C2.

As assessed by immunostaining of tissue sections and cytospin slides, primary neoplastic mast cells (MC) and C2 cells were found to express the VEGF protein.

In Northern blot and RT-PCR experiments, C2 cells expressed VEGF mRNA in a constitutive manner. VEGF mRNA expression in C2 cells was counteracted by LY294002 and rapamycin, suggesting involvement of the PI3-kinase/mTOR pathway.

Moreover, C2 cells were found to express VEGF receptor-1 (Flt-1) and VEGF receptor-2 (KDR).

However, recombinant VEGF failed to promote (3)H-thymidine uptake in C2 cells, and a neutralizing anti-VEGF antibody (bevacizumab) failed to downregulate spontaneous proliferation in these cells.

In addition, rapamycin decreased the expression of VEGF in C2 cells at the mRNA and protein level without suppressing their proliferation.

Together, canine mastocytoma cells express VEGF as well as VEGF receptors. However, despite co-expression of VEGF and its receptors, VEGF is not utilized as an autocrine growth regulator by canine mastocytoma cells.



Source: Rebuzzi L, et al (2007): Detection of vascular endothelial growth factor (VEGF) and VEGF receptors Flt-1 and KDR in canine mastocytoma cells. In: Vet Immunol Immunopathol. 2007 Feb 15;115(3-4):320-33. Epub 2006 Nov 17.



Tell a friend   |   Print version   |   Send this article

SMALL ANIMAL PRACTICE

Surgical outcome of cats treated for aqueous humor misdirection syndrome
Feline aqueous humor misdirection syndrome is occasionally seen in cats and can be difficult to treat. This recently online published case series evaluates the clinical outcome of cats treated surgically for aqueous humor misdirection syndrome.

  • Treatment of limbal melanoma with surgical debulking plus diode laser
  • Novel technique to place feeding tubes in small animalsmembers
  • Epidemiology and clinical presentation of canine cataracts in France
  • Use of a Surgical Safety Checklistmembers
  • NGAL in dogs with chronic kidney diseasemembers
  • Long-term Outcome of Irish Wolfhound Dogs with different heart medicationsmembers
  • Simple technique for autotransfusion in dogsmembers
  • General anesthesia with an injectable 8% v/v sevoflurane lipid emulsion in dogsmembers
  • Carboplatin sustained-release delivery system in dogs with cancermembers
  • Wound bio-burden and prevalence of multi-drug resistant bacteria in open woundsmembers
  • Concurrent perioperative use of marbofloxacin and cimicoxib or carprofenmembers
  • Topical hyaluronic acid and the corneal wound healing members


  • [ Home ] [ About ] [ Contact / Request ][ Disclaimer ]

    Copyright © 2001-2016 VetContact GmbH
    All rights reserved